Congress funds research on breast cancer hitting Black women three times harder

What it does

This bill directs the National Institutes of Health to expand research on triple-negative breast cancer (a particularly aggressive form that disproportionately affects African-American and Hispanic women) and requires the CDC and Health Resources and Services Administration to develop and distribute public education and provider training materials about the disease. The bill authorizes funding for these activities through fiscal year 2031 but does not appropriate specific dollar amounts.

Why we flagged it

The bill is a straightforward authorization for federal research and education programs targeting a specific disease with documented health disparities. It contains no tax provisions, subsidies, or private carve-outs—only directives to federal agencies and open-ended appropriations authority.

What the text implies

• The bill's findings document a 3x higher incidence of TNBC in African-American women vs. White women, establishing a health-equity rationale that may support future targeted interventions or resource allocation decisions.
• Authorization of research through 2031 creates a six-year research pipeline; actual funding depends on annual appropriations, so the bill's impact is contingent on Congress following through with budget allocations.
• The requirement that CDC and HRSA disseminate information 'directly or through arrangements with nonprofit organizations' may create opportunities for patient advocacy groups and medical societies to shape messaging and clinical guidance.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill funds research and education on a disease with documented disparities in incidence and survival outcomes, particularly affecting African-American and Hispanic women. Citizens benefit from expanded research capacity, public awareness, and provider training on a cancer type that is aggressive and undertreated.

Who stands to gain

• National Institutes of Health (research funding)
• Centers for Disease Control and Prevention (education program funding)
• Health Resources and Services Administration (provider training funding)
• Academic medical centers and research institutions (NIH grant recipients)
• Nonprofit health organizations and patient advocacy groups (potential education partners)

Named in the bill

National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Health Resources and Services Administration (HRSA), Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Environmental Health Sciences, Office of Research on Women's Health, National Institute on Minority Health and Health Disparities, Public Health Service Act, Department of Health and Human Services

Where it stands

13 cosponsors: 11 Democrats, 2 Republicans.

• Mar 3, 2025 — Introduced · Congress.gov: “Introduced in House”
• Mar 3, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.